Valeant CEO to tell Senate committee drug price increases were ‘too aggressive’ By: MarketWatch April 27, 2016 at 08:53 AM EDT Valeant CEO Pearson will testify before a Senate committee Wednesday. Read More >> Related Stocks: Valeant Pharmaceuticals International, Inc.